OBI Pharma announces U.S. FDA clearance of IND application for a Phase 1/2 study of...

The NMPA has granted breakthrough-therapy-designated drug for B7-H4-targeted antibody-drug conjugate HS-20089

Innate Pharma highlights preclinical anti-tumor efficacy data of its antibody drug conjugate IPH4502 at the...

Araris Biotech AG announces research agreement to develop next-generation ADCs using Araris’ AraLinQ technology

DCx accelerates multi-modal ADC development

Chinese biotech inks ADC platform deal with ConjugateBio